TIFU: A Non-Interventional, Descriptive Cohort Study to Describe the Use of Ticagrelor in Patients With Acute Coronary Syndrome (TIFU: Ticagrelor in Fuwai Hospital)
Latest Information Update: 16 Jun 2021
At a glance
- Drugs Ticagrelor (Primary)
- Indications Acute coronary syndromes; Thromboembolism
- Focus Adverse reactions
- Acronyms TIFU
- 17 Aug 2020 Status changed from recruiting to completed, according to Results published in the Platelets.
- 31 Jul 2016 Status changed from not yet recruiting to recruiting.
- 11 May 2016 New trial record